Electrocardiographic left ventricular hypertrophy predicts atrial fibrillation independent of left ventricular mass

Nikhil Patel1, Wesley T O'Neal2, S Patrick Whalen1

  • 1Section of Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Insights

Electrocardiography-left ventricular hypertrophy (ECG-LVH) and echocardiography-left ventricular hypertrophy (echo-LVH) independently predict atrial fibrillation (AF). These findings suggest distinct electrophysiological abnormalities contribute to AF risk.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Preventive Medicine

Background:

  • Left ventricular hypertrophy (LVH) is a known cardiovascular risk factor.
  • The independent predictive value of ECG-LVH and echo-LVH for atrial fibrillation (AF) remains unclear.

Purpose of the Study:

  • To determine if ECG-LVH and echo-LVH independently predict incident AF.
  • To investigate the relationship between ECG-LVH, echo-LVH, and AF risk.

Main Methods:

  • Analysis of 4,904 participants from the Cardiovascular Health Study, free of baseline AF.
  • ECG-LVH defined by Minnesota Code Classification; echo-LVH defined by sex-specific left ventricular mass.
  • Cox regression used to assess the association of ECG-LVH and echo-LVH with incident AF.

Main Results:

  • ECG-LVH (4.6%) and echo-LVH (4.7%) were independently associated with incident AF (HR=1.50 and HR=1.39, respectively).
  • In a combined model, both ECG-LVH (HR=1.47) and echo-LVH (HR=1.36) remained significant predictors of AF.
  • Over 11.9 years median follow-up, 1,430 AF events were recorded.

Conclusions:

  • ECG-LVH predicts AF independently of left ventricular mass measured by echocardiography.
  • Cardiac electrophysiological abnormalities offer a distinct risk profile for predicting AF.
  • Both ECG and echocardiography findings of LVH contribute to AF risk prediction.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
731
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
807
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
753
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
373